+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of dyslipidemias in autoimmune rheumatic diseases



Prevalence of dyslipidemias in autoimmune rheumatic diseases



Journal of the College of Physicians and Surgeons--Pakistan 22(4): 235-239



To determine the frequency of dyslipidemias in various autoimmune rheumatic diseases and the difference in lipid profile according to the activity of these diseases. Cross-sectional study. The Rheumatology Department of Pakistan Institute of Medical Sciences (PIMS), Islamabad, from May 2010 to April 2011. All patients who presented to Rheumatology Department with various autoimmune inflammatory rheumatic diseases were included. Fasting lipid profiles of patients were obtained after an overnight fast of 12 hours. Various diseases were classified as active or inactive on the basis of clinical features and relevant laboratory tests. Data were entered in SPSS 17 and analyzed. Association between disease activity and abnormal lipid profile was also determined. A total of 100 patients were included in the study. Out of these, 82% were females. Mean age was 34.15 ± 7.73 years. Rheumatoid arthritis (RA) was the most common disease present in 78 patients. Various types of dyslipidemias were found in 54% of patients. Low HDL and deranged cholesterol levels were significantly associated with active disease (p = 0.044 and p = 0.048 respectively). Patients with RA also had dyslipidemias in 45% of the cases. Disturbed cholesterol level was observed in active RA (p = 0.044). Dyslipidemias are frequent among the patients with autoimmune rheumatic diseases (AIRD). Disturbance in total cholesterol is the most common abnormality with a significant association with disease activity.

(PDF emailed within 1 workday: $29.90)

Accession: 055157420

Download citation: RISBibTeXText

PMID: 22482380


Related references

High prevalence of hypovitaminosis D of patients with autoimmune rheumatic diseases in China. American Journal of Clinical and Experimental Immunology 5(3): 48-54, 2016

Dyslipidemias and autoimmune diseases. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1999(12): 43-45, 1999

Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases. Clinical and Experimental Rheumatology 36(1): 121-126, 2017

The prevalence of antibodies to the major heat shock proteins 90 and 70 in children with autoimmune rheumatic diseases. Arthritis & Rheumatism 37(9 SUPPL ): S316, 1994

Prevalence of thyroid autoantibodies in patients with systematic autoimmune rheumatic diseases. Cross-sectional study. Sao Paulo Medical Journal 135(6): 535-540, 2018

Low prevalence of anti-DFS70/LEDGF antibodies in patients with dermatomyositis and other systemic autoimmune rheumatic diseases. Journal of Rheumatology 40(1): 92-93, 2013

Prevalence and incidence in patients with autoimmune rheumatic diseases: a nationwide population-based study in Taiwan. Arthritis Care and Research 65(2): 244-250, 2013

The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates. Rheumatology International 35(3): 569-573, 2016

Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts. Clinica Chimica Acta; International Journal of Clinical Chemistry 472: 1-4, 2017

Malignant neoplasms in autoimmune rheumatic diseases: examination of the risk of developing a malignancy among five different rheumatic diseases in one institution. Journal of Clinical Rheumatology 6(4): 176-183, 2000

Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China. Apmis 124(9): 805-811, 2017

Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases. Medicine 95(38): E4336, 2017

Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases. Arthritis Research and Therapy 18(1): 276, 2017

Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two-steps strategy using a self-administered questionnaire and autoantibody testing. Bjog 115(1): 51-57, 2007

Prevalence of dyslipidemias and correlation with cardiovascular diseases. International Journal of Obesity 24(Supplement 1): S82, 2000